Zai Lab ZLAB
NASDAQ ZLAB
$26.12 -0.88 (-3.26%)
As of: Sep 4, 2026 · 1:34 PM EDT

Zai Lab (ZLAB) Retained Earnings (2016 - 2026)

Zai Lab (ZLAB) posted Retained Earnings of -$2.7 billion for Q1 2026, down 1.94% sequentially from -$2.6 billion in Q4 2025, and down 7.12% YoY from -$2.9 billion in Q1 2025.

Analysis

Zai Lab (ZLAB) Retained Earnings (2016 - 2026) Analysis & Trends

Zai Lab has reported Retained Earnings for 11 years, with the latest figure at -$2.7 billion in Q1 2026.

  • Quarterly Retained Earnings fell 7.12% year-over-year to -$2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 billion (down 7.12% YoY) and the FY2025 annual result came in at -$2.6 billion, down 7.16% from the prior year.
  • Retained Earnings slipped to -$2.7 billion in Q1 2026 per ZLAB's latest filing, from -$2.6 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at -$1.5 billion in Q1 2022 and troughed at -$2.7 billion in Q1 2026.
  • A 5-year average of -$2.2 billion and a median of -$2.2 billion in 2024 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2026: Retained Earnings plunged 58.53% in 2022, then dropped 7.12% in 2026.
  • Over 5 years, Retained Earnings stood at -$1.9 billion in 2022, then declined by 17.98% to -$2.2 billion in 2023, then declined by 11.71% to -$2.5 billion in 2024, then retreated by 7.16% to -$2.6 billion in 2025, then declined by 1.94% to -$2.7 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$2.7 billion, -$2.6 billion, and -$2.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 558.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -4.00 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 4.38 Bn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 6.57 Bn
10 Zai Lab 2.91 Bn 2.21 Bn 58.15 Mn -2.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.73 Bn
Mar 31, 2026 -2.68 Bn
Dec 31, 2025 -2.63 Bn
Sep 30, 2025 -2.58 Bn
Jun 30, 2025 -2.54 Bn
Mar 31, 2025 -2.50 Bn
Dec 31, 2024 -2.45 Bn
Sep 30, 2024 -2.37 Bn
Jun 30, 2024 -2.33 Bn
Mar 31, 2024 -2.25 Bn
Dec 31, 2023 -2.20 Bn
Sep 30, 2023 -2.10 Bn
Jun 30, 2023 -2.03 Bn
Mar 31, 2023 -1.91 Bn
Dec 31, 2022 -1.86 Bn
Sep 30, 2022 -1.80 Bn
Jun 30, 2022 -1.64 Bn
Mar 31, 2022 -1.50 Bn
Dec 31, 2021 -1.42 Bn
Sep 30, 2021 -1.21 Bn